ArriVent BioPharma, Inc. - Common Stock (AVBP)

ArriVent BioPharma, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative therapies to address unmet medical needs in various disease areas

The company leverages cutting-edge research and advanced clinical development strategies to create targeted treatments, particularly in oncology and other serious diseases. By prioritizing scientific rigor and collaborative partnerships, ArriVent aims to bring transformative solutions to patients and improve health outcomes globally.